ライフサイエンスコーパス: fine-needle aspiration

1 center reactions, as assessed by lymph node fine needle aspiration.

2 lymph node status defined by ultrasound and fine needle aspiration.

3 mproved in resolution and ability to perform fine needle aspiration.

4 preparations obtained by minimally invasive fine needle aspiration.

5 adiologic evaluations, and early performance fine-needle aspiration.

6 ther than in tissue removed surgically or by fine-needle aspiration.

7 us harms from screening or ultrasound-guided fine-needle aspiration.

8 oid compression source were performed before fine-needle aspiration.

9 tment is currently done on tumor biopsies or fine-needle aspirations.

10 core-needle biopsy (50% [17/34] P = .04) and fine needle aspiration (0% [0/2]; P = .009).

11 e procured with endoscopic ultrasound-guided fine-needle aspiration 1 week before and 2 weeks after c

12 multicentric breast lesions proven by either fine-needle aspiration (19/59), core biopsy (39/59), or

13 ), and set 2-95 endoscopic ultrasound-guided fine-needle aspirations (60 PDAC, 9 IPMN, 26 C).

14 ion (93%), and ultrasound guided parathyroid fine needle aspiration (78%).

15 the combination of endoscopic ultrasound and fine-needle aspiration analysis for KIT expression may b

16 ules that are cytologically indeterminate on fine-needle aspiration and benign according to gene-expr

17 Fine-needle aspiration and biopsy of bone led to reduced

18 In patients undergoing both fine-needle aspiration and biopsy, the former proved dia

19 Both fine-needle aspiration and intraoperative frozen section

20 less invasive techniques such as testicular fine-needle aspiration and percutaneous needle biopsy ar

21 P and may provide a tissue diagnosis through fine-needle aspiration and staging through ultrasound im

22 ence of ductal carcinoma-in-situ, the use of fine-needle aspiration and stereotactic biopsy for diagn

23 which can improve the diagnostic accuracy of fine-needle aspirations and provide prognostic informati

24 l image analysis, endoscopic ultrasound with fine needle aspiration, and cholangioscopy.

25 reoperative studies such as ultrasonography, fine-needle aspiration, and better molecular and genetic

26 Endoscopy and endoscopic ultrasound-guided, fine-needle aspiration are key components in the diagnos

27 30% of thyroid nodules evaluated by means of fine-needle aspiration are not clearly benign or maligna

28 ical problems such as the suspicious thyroid fine needle aspiration, better treatment algorithms for

29 chnology now allow the detection of these in fine needle aspiration biopsies (FNA).

30 orphological evaluation can be acquired with fine-needle aspiration biopsies (FNAB) controlled with C

31 ression data (gene chips) was generated from fine-needle aspiration biopsies (n = 229) prospectively

32 trations of human Tg from needle washouts of fine-needle aspiration biopsies of thyroid nodule from d

33 A total of 209 fine-needle aspiration biopsies were performed on 156 pa

34 m tumors were conducted and compared with 86 fine-needle aspiration biopsies(FNAB) of lung and medias

35 ee detection of Tg in the needle washouts of fine-needle aspiration biopsies, at concentrations usefu

36 The majority of nodules with fine needle aspiration biopsy (FNAB) results that are cl

37 Perform the first in vivo examination of fine needle aspiration biopsy (FNAB) scleral tracts to d

38 e diagnosis was made using ultrasound-guided fine needle aspiration biopsy and consequent cytopatholo

39 pplied to improve the diagnostic accuracy of fine needle aspiration biopsy and cytologic examination.

40 Mutation analysis in thyroid nodule fine needle aspiration biopsy has been applied to improv

41 iomarkers that could improve the accuracy of fine needle aspiration biopsy in the evaluation of patie

42 in one patient and a percutaneous CT-guided fine needle aspiration biopsy in the other disclosed nor

43 l line were originated simultaneously from a fine needle aspiration biopsy of a metastasis in a patie

44 etrieve lower respiratory tract samples; and fine needle aspiration biopsy of lymph nodes.

45 Fine needle aspiration biopsy of tumors was done at base

46 d cancer that are beginning to be applied in fine needle aspiration biopsy samples to improve diagnos

47 Fine needle aspiration biopsy was done and revealed no a

48 differential diagnosis of thyroid tumors by fine needle aspiration biopsy, specifically suspicious o

49 lly or histologically proved after US-guided fine-needle aspiration biopsy (eight lesions) or core bi

50 Endosonography-guided fine-needle aspiration biopsy (EUS-FNA) permits cytologi

51 s with posterior uveal melanoma evaluated by fine-needle aspiration biopsy (FNAB) at the time of or s

52 Fine-needle aspiration biopsy (FNAB) for DNA amplificati

53 Fine-needle aspiration biopsy (FNAB) of tumor for DNA am

54 most potentially devastating complication of fine-needle aspiration biopsy (FNAB) or open biopsy is e

55 utility of BRAF mutation testing of thyroid fine-needle aspiration biopsy (FNAB) specimens for preop

56 9 to July 2013 who underwent prognostication fine-needle aspiration biopsy (FNAB) were included.

57 w curved linear-array instruments, real-time fine-needle aspiration biopsy (RTFNA) of pancreatic lesi

58 8q, as well as sex, source of tumor tissue (fine-needle aspiration biopsy [FNAB] compared with tumor

59 Fine-needle aspiration biopsy also allows characterizati

60 te thyroid nodules; and peripheral blood and fine-needle aspiration biopsy analysis of molecular mark

61 Fine-needle aspiration biopsy and core biopsy are import

62 Percutaneous fine-needle aspiration biopsy can be used for the diagno

63 Fine-needle aspiration biopsy confirmed the diagnoses (n

64 Clear corneal fine-needle aspiration biopsy confirmed the diagnosis as

65 versely, some population-based studies using fine-needle aspiration biopsy data report no linkage bet

66 The preferred approach when repeated fine-needle aspiration biopsy fails to yield an adequate

67 5 brachytherapy and underwent intraoperative fine-needle aspiration biopsy for cytopathology and uvea

68 Fine-needle aspiration biopsy for metastatic prognostica

69 Fine-needle aspiration biopsy for prognostication in cho

70 Core-needle biopsy in comparison to fine-needle aspiration biopsy has more frequent rate of

71 Fine-needle aspiration biopsy has resulted in substantia

72 Fine-needle aspiration biopsy identifies the childhood t

73 US-guided fine-needle aspiration biopsy is a simple, rapid, inexpe

74 Fine-needle aspiration biopsy is an alternative to open

75 Fine-needle aspiration biopsy is both accurate and cost-

76 Fine-needle aspiration biopsy is more reliable in distin

77 Fine-needle aspiration biopsy is not perfect and adjunct

78 Tissue sampling with fine-needle aspiration biopsy is recommended.

79 Fine-needle aspiration biopsy is the standard diagnostic

80 Fine-needle aspiration biopsy MT for BRAF, RAS, PAX8-PPA

81 0 for "highly suggestive of malignancy." For fine-needle aspiration biopsy of a palpable lump perform

82 The diagnosis was made by fine-needle aspiration biopsy of a pulmonary nodule.

83 Fine-needle aspiration biopsy of choroidal melanoma offe

84 ry 2012 to December 2014 from intraoperative fine-needle aspiration biopsy of choroidal tumors underg

85 Fine-needle aspiration biopsy of large thyroid nodules h

86 d ultrasonography and ultrasonography-guided fine-needle aspiration biopsy of nodules at least 1 cm i

87 nodes and as a guidance system for directed fine-needle aspiration biopsy of suspicious lesions.

88 Ultrasound (US)-guided fine-needle aspiration biopsy of the largest node reveal

89 Ultrasonography (US)-guided fine-needle aspiration biopsy of the left anterior chest

90 l melanoma may be directed by the results of fine-needle aspiration biopsy of the primary tumor.

91 r vitrectomy followed by transvitrector port fine-needle aspiration biopsy of the tumor immediately b

92 abilities, either computed tomography-guided fine-needle aspiration biopsy or positron emission tomog

93 16 of 680) of malignancies would not undergo fine-needle aspiration biopsy or surgery if the SRU guid

94 Either fine-needle aspiration biopsy or ultrasonography is reco

95 oid cancer incidence is increasing, and when fine-needle aspiration biopsy results are cytologically

96 tive review of 2,988 consecutive stereotaxic fine-needle aspiration biopsy samples of nonpalpable bre

97 MN/CA9 protein in histological sections and fine-needle aspiration biopsy smears of normal kidney, b

98 an algorithm for prospective MT of in-house fine-needle aspiration biopsy specimens, we conducted a

99 ly can augment the diagnostic specificity of fine-needle aspiration biopsy to better differentiate cy

100 Fine-needle aspiration biopsy was used in 10 cases and c

101 at, gray-scale thyroid ultrasonography and a fine-needle aspiration biopsy were performed.

102 ary nodal metastases confirmed by results of fine-needle aspiration biopsy who had a clip placed in t

103 sibly followed by computed tomography-guided fine-needle aspiration biopsy, is best.

104 Studies were included if 1) mammography, fine-needle aspiration biopsy, or core-needle biopsy was

105 onography (US)-guided core biopsy, US-guided fine-needle aspiration biopsy, surgical excision, and mu

106 ere found to be papillary thyroid cancers at fine-needle aspiration biopsy.

107 st studies, nodule cytology was evaluated by fine-needle aspiration biopsy.

108 graphic follow-up had been recommended after fine-needle aspiration biopsy.

109 important issue undermining the benefits of fine-needle aspiration biopsy.

110 ture of thyroid abscess material obtained by fine-needle aspiration biopsy.

111 ion for thyroid nodules is ultrasound-guided fine-needle aspiration biopsy.

112 Endoscopic ultrasound-fine needle aspiration can be helpful in detecting local

113 characteristics plus follow-up cytology from fine-needle aspiration can identify thyroid cancers, it

114 In 138 (66%), findings at previous fine-needle aspiration cytologic (FNAC) analysis were no

115 Diagnosis is based on fine-needle aspiration cytologic examination.

116 mode of diagnosis, thus avoiding unnecessary fine needle aspiration cytologies.

117 w dominated by the application of EUS-guided fine needle aspiration cytology (EUS-FNA), and the newes

118 Thyroid fine needle aspiration cytology (FNAC) is the standard d

119 Fine needle aspiration cytology is central to the evalua

120 d nodules 1 cm or larger with ultrasound and fine-needle aspiration cytology (FNA).

121 er axillary ultrasound (AUS) after NAC after fine-needle aspiration cytology can identify abnormal no

122 section.Preoperative axillary ultrasound and fine-needle aspiration cytology has recently been shown

123 laparoscopy, endoscopic ultrasonography, and fine-needle aspiration cytology to identify 38 patients

124 of which lesions should be followed without fine-needle aspiration cytology.

125 n age of 55 years (range, 23-85 years) and a fine-needle aspiration diagnosis of atypia of undetermin

126 e, extrathyroidal extension, or a definitive fine-needle aspiration diagnosis.

127 EUS, EUS-guided fine needle aspiration (EUS-fine needle aspiration), emerging cytologic markers obta

128 gs regarding the accuracy of EUS, EUS-guided fine needle aspiration (EUS-fine needle aspiration), eme

129 atic disease, and endoscopic ultrasound with fine needle aspiration (EUS-FNA) remain the preferred me

130 EBUS-TBNA, then endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) was allowed as an alter

131 Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) was evaluated as a sing

132 The role of EUS-guided fine-needle aspiration (EUS FNA) in this setting is uncl

133 diagnosed by endoscopic, ultrasound-guided, fine-needle aspiration (EUS-FNA) biopsy and were resecte

134 urs obtained by endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) for diagnosis of metast

135 sive technique (endoscopic ultrasound-guided fine-needle aspiration [EUS-FNA]) is capable of sampling

136 erminate or suspicious cytologic features on fine needle aspiration (FNA) biopsy require thyroidectom

137 A similar ex vivo analysis was performed on fine needle aspiration (FNA) biopsy samples from four mu

138 The molecular work-up of thyroid nodules on fine needle aspiration (FNA) cytology samples has given

139 Subsequent diagnostics included fine needle aspiration (FNA) of suspicious lesions and m

140 We amplified RNAs from 63 fine needle aspiration (FNA) samples from 37 s.c. melano

141 n be detected and sampled effectively by EUS-fine needle aspiration (FNA).

142 One-time evaluation with fine-needle aspiration (FNA) and combinations of chemica

143 Clinical specimens obtained through fine-needle aspiration (FNA) and excisional biopsy were

144 computed tomography (CT)-guided percutaneous fine-needle aspiration (FNA) has become the procedure of

145 Fine-needle aspiration (FNA) is increasing in popularity

146 specificity of ultrasonographic (US)-guided fine-needle aspiration (FNA) of axillary lymph nodes for

147 CT-guided fine-needle aspiration (FNA) of lung lesions is subject

148 Fine-needle aspiration (FNA) of thyroid nodules has beco

149 Fine-needle aspiration (FNA) or stereotactic core biopsy

150 Data from 195 fine-needle aspiration (FNA) samples were used to define

151 cer, and molecular testing of thyroid nodule fine-needle aspiration (FNA) specimens has been proposed

152 hologic staging can be achieved at EUS using fine-needle aspiration (FNA) to obtain cytology from sus

153 rough the combination of imaging and guided, fine-needle aspiration (FNA).

154 are not simple cysts should be studied with fine-needle aspiration (FNA).

155 undergoing endoscopic ultrasonography (EUS) fine-needle aspiration (FNA).

156 Cytological study of EUS-guided fine needle aspiration from the mass was suggestive of s

157 ed TAA expression in metastases by obtaining fine-needle aspirations from 52 tumor lesions in 30 pati

158 The evaluation of thyroid nodules by fine-needle aspiration has been the standard for almost

159 ews the role of endoscopic ultrasound-guided fine-needle aspiration in diagnosing various pancreatic

160 nostic yield of endoscopic ultrasound-guided fine needle aspiration include performing cyst wall cyto

161 doscopic characterization of the lesion with fine needle aspiration is critical for treatment decisio

162 Endoscopic ultrasound-guided fine needle aspiration is generally adequate for tissue

163 Lymph node fine-needle aspiration is positive for malignant cells.

164 e evaluation by endoscopic ultrasound-guided fine needle aspiration may further expand the role of en

165 tissue sampling with core-needle (n = 6) or fine-needle aspiration (n = 20) biopsy, corticosteroid o

166 Diagnosis was established with fine-needle aspiration (n = 55), 14-gauge core-needle bi

167 Fine needle aspiration of a right axillary node confirme

168 We show that fine needle aspiration of cancer provides a fast and eff

169 Fine needle aspiration of the mass suggested a diagnosis

170 g by facilitating tissue acquisition through fine needle aspiration of the tumor and surrounding lymp

171 grade 2 of 3 on core biopsy, with a positive fine-needle aspiration of a palpable, ipsilateral axilla

172 applied minimally invasive ultrasound-guided fine-needle aspiration of the LN to a before-and-after s

173 CT-guided fine-needle aspiration of the splenic lesion was perform

174 graphy and endoscopic ultrasonography-guided fine-needle aspiration offer high diagnostic ability for

175 re collected by endoscopic ultrasound-guided fine-needle aspiration or surgery and were preserved as

176 d malignancy, the need for ultrasound-guided fine needle aspiration, preoperative staging, lymph node

177 The finding of a follicular neoplasm on fine-needle aspiration prompts many surgeons to perform

178 e RS, and 148 patients (3.7%) had biopsy- or fine-needle aspiration-proven RS.

179 vacuum assisted needle biopsy, image-guided fine needle aspiration, punch biopsy, and open surgical

180 jects scheduled for surgery after a previous fine-needle aspiration report of "atypia of undetermined

181 Pancreatic endoscopic ultrasound with fine needle aspiration revealed cytomorphologic features

182 n), emerging cytologic markers obtained from fine needle aspiration samples, and the role of EUS scre

183 lar analysis of endoscopic ultrasound-guided fine-needle aspiration samples has the potential to impr

184 amples, to predict chemotherapy responses in fine-needle aspiration samples in neoadjuvant chemothera

185 these miRNAs in endoscopic ultrasound-guided fine-needle aspiration samples makes them good biomarker

186 Fine needle aspiration should be considered in adolescen

187 ients with a solitary thyroid nodule in whom fine-needle aspiration showed a follicular neoplasm.

188 her enhanced by the ability to obtain guided fine needle aspiration specimens for cytology from any s

189 erformed with oligonecleotide microarrays on fine-needle aspiration specimens.

190 bulin antibodies, positive results on recent fine-needle aspiration, suspected enlarging mass, and ab

191 ere is controversy regarding the role of EUS fine-needle aspiration, the findings of which may enhanc

192 Fine-needle aspiration, the presence of extraintestinal

193 scan with intravenous contrast and possible fine needle aspiration to detect the presence of sterile

194 Although no difference was found for fine-needle aspiration versus core biopsy of malignant l

195 Hepatic fine needle aspiration was performed before treatment an

196 EUS-guided fine-needle aspiration was performed on sites that were